Studies have confirmed that ER levels can affect the invasive and metastatic phenotype of breast cancers by regulating the expression of E-cad via the ER-metastasis-associated protein MTA3-Snail-E-cad signaling pathway [34, 35]. This evidence concerns the gene MTA3 and breast carcinoma.